← Back to headlines
Emergent BioSolutions Secures $34.5 Million Vaccine Deal
Emergent BioSolutions has signed a $34.5 million deal for vaccine manufacturing and distribution.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
